Management of bone loss in postmenopausal breast cancer patients treated with aromatase inhibitors
Main Author: | Margarida Maria Duarte da Silva Cepa |
---|---|
Other Authors: | Faculdade de Medicina |
Format: | Others |
Language: | English |
Published: |
2019
|
Subjects: | |
Online Access: | https://repositorio-aberto.up.pt/handle/10216/88704 |
Similar Items
-
Biological Evaluation of New Compounds as Potential Aromatase Inhibitors for Estrogen-Dependent Breast Cancer
by: Maria Fernanda Dias Miranda Bernardo
Published: (2019) -
Aromatase inhibitors in breast cancer: Drug discovery and strategies to overcome acquired resistance
by: Tiago André Sousa Vieira Augusto
Published: (2021) -
7 α-allylandrostanes as new aromatase inhibitors: biological effects in hormone-dependent and hormone-resistant breast cancer cells
by: João Carlos Pais Maurício
Published: (2019) -
Cardiac Toxicity in Breast Cancer Patients Treated with Adjuvant Trastuzumab
by: Lara Isabel Pires Luís
Published: (2019) -
The Role of CCL2 in Breast Cancer: A Possible Modulator of Iron Homeostasis in Neoplastic Context
by: Ana Margarida Alves Oliveira da Rosa
Published: (2019)